LifeStance Health Group, Inc. (LFST)

LifeStance Health Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	49.45	78.82	108.62	148.03
Cash & Cash Equivalents	49.45	78.82	108.62	148.03
Cash Growth	-27.59%	-27.43%	-26.62%	-
Receivables	175.94	125.41	100.87	76.08
Other Current Assets	18.73	21.5	23.73	42.41
Total Current Assets	244.12	225.73	233.22	266.52
Property, Plant & Equipment	348.27	358.93	393.62	152.24
Goodwill and Intangibles	1,502	1,514	1,536	1,505
Other Long-Term Assets	12.05	10.9	10.8	3.45
Total Long-Term Assets	1,862	1,884	1,941	1,661
Total Assets	2,106	2,110	2,174	1,927
Accounts Payable	11.94	7.05	12.29	14.15
Current Debt	49.73	46.48	38.82	0
Other Current Liabilities	145.8	149.35	124.89	102.6
Total Current Liabilities	207.46	202.87	176	116.75
Long-Term Debt	453.13	461.64	437.67	157.42
Other Long-Term Liabilities	16.73	16.52	41.48	107.91
Total Long-Term Liabilities	469.86	478.17	479.15	265.33
Total Liabilities	677.32	681.04	655.15	382.08
Total Debt	502.85	508.12	476.49	157.42
Debt Growth	6.02%	6.64%	202.69%	-
Retained Earnings	-781.94	-760.85	-572.64	-357.07
Comprehensive Income	2.89	2.3	3.27	0
Shareholders' Equity	1,429	1,429	1,519	1,545
Net Cash / Debt	-453.4	-429.29	-367.87	-9.39
Net Cash Per Share	-1.20	-1.17	-1.04	-0.03
Working Capital	36.65	22.86	57.22	149.77
Book Value Per Share	3.80	3.89	4.28	4.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).